Cradle vs Nimbus Therapeutics

Cradle vs Nimbus Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cradle is on 69/100 and Nimbus Therapeutics on 51/100.

Cradle logo
CradleCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Try Cradle
Nimbus Therapeutics logo
Nimbus TherapeuticsNimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
Try Nimbus Therapeutics

Where each one leads

Cradle

  • our overall score: 69/100 against 51/100
  • agent readiness: 44/100 against 27/100

Nimbus Therapeutics

  • funding raised: $589M against $102M

At a glance

MeasureCradleNimbus Therapeutics
What it isCradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is baseNimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
CategoryBiotech, HealthTech, AI-Driven Protein Design, Drug DiscoveryBiotechnology, Drug Discovery, AI, Machine Learning
Sells toBusiness modelB2BB2B
OfferingSoftware | platformServices
Founded20212009
HeadquartersAmsterdam, NetherlandsBoston, United States
StatusActiveActive

Size, funding and growth

MeasureCradleNimbus Therapeutics
Employees112Not published
Total funding$102M$589M
Latest roundSeries BSeries F
LinkedIn followers27,926Not published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCradleNimbus Therapeutics
StartupHub scoreOur 0-100 rating69/10051/100
Traction60/10040/100
Team70/10030/100
Community17/1008/100
Search visibility56/10018/100
Quality78/10070/100
Agent readinessHow well an AI agent can read and act on the siteD (44/100)F (27/100)
Domain ratingLink authority, 0-10053/10055/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCradleNimbus Therapeutics
HostingNot detectedGoogle Cloud
CMSFramerWordPress
AnalyticsNot detectedGoogle Analytics 4, Segment, Microsoft Clarity

Cradle vs Nimbus Therapeutics: common questions

Which is better, Cradle or Nimbus Therapeutics?

On our 0-100 score Cradle rates higher (69/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do Cradle and Nimbus Therapeutics compare on the numbers?

Cradle leads on our overall score (69/100 against 51/100), agent readiness (44/100 against 27/100). Nimbus Therapeutics leads on funding raised ($589M against $102M).

Read the full Cradle review and pricing or the Nimbus Therapeutics review and pricing. You can also browse other Cradle alternatives we track.